H.C. Wainwright Maintains Candel Therapeutics(CADL.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsNov 19 03:36 ET · Ratings

Candel Therapeutics Advances in Cancer Trials Amid Financial Challenges

TipRanksNov 18 22:54 ET

Express News | HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $11 Price Target

BenzingaNov 18 07:50 ET

Candel Therapeutics Analyst Ratings

BenzingaNov 18 07:49 ET · Ratings

Promising Potential of Candel Therapeutics' CAN-2409 Drives Buy Rating

TipRanksNov 18 06:26 ET · Ratings

Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer

BusinesswireNov 18 05:30 ET